US government renews COVID-19 vaccine distribution agreement with Palantir

Continuing its partnership with the US Department of Health and Human Services (HHS), Palantir will help distribute COVID-19 vaccines for the second straight year.

In the U.S. and abroad, Palantir has been instrumental in mitigating the COVID-19 pandemic, supporting more than 100 organizations, including the UK's National Health Service, the US government and military, and more.

The HHS commissioned Palantir to develop Tiberius in mid-2020. Using the Tiberius platform, federal health officials could track the production, distribution, and administration of vaccines across the country.

The renewed contract will continue Palantir's support for Tiberius. In collaboration with HHS's Office of the Chief Information Officer (OCIO), Palantir will help strengthen the US’ COVID-19 vaccine distribution strategy, facilitate international distribution, and improve the equity and efficacy of vaccine programs.

Palantir's Tiberius integrates disparate data sources into a common operating picture, allowing organizations to make informed decisions. Additionally, as part of its one-year contract with the government, Palantir will help distribute US-donated vaccines worldwide.

“We are proud to have supported HHS in administering one of the most successful and rapid vaccine rollouts in the world,” said Akash Jain, president of Palantir USG.

Jain added, “As new variants emerge and pose a renewed risk to public health in the United States and around the world, we are humbled to have earned the confidence of HHS once again to help support its lifesaving work.”

Earlier this year, New York state officials unveiled Excelsior Pass, a free smartphone app that verifies recent negative PCR test results or vaccination records.

On the contrary, the head of the Information Commissioner’s Office (ICO) has warned that plans to introduce COVID-19 vaccine certification are unlikely to succeed until ministers gain public trust.